Re: Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer. Fernandez-Zapata WF, Gandur Quiroga MN, Cardona Maya WD. Eur Urol 2023 Dec 11:S0302-2838(23)03283-9. doi: 10.1016/j.eururo.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Fernandez-Zapata WF, Gandur Quiroga MN, Cardona Maya WD. Re: Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer. Eur Urol 2023 Dec 11:S0302-2838(23)03283-9. doi: 10.1016/j.eururo.2023.
PMID: 38087734